Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Biol Neonate ; 57(2): 88-97, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2106921

RESUMEN

We studied the intestinal flora of 23 newborns, whose meconium had yielded a pure culture of Pseudomonas aeruginosa on blood agar medium. Twelve infants had a single serotype of P. aeruginosa in their meconium, 10 had a second serotype and the last infant was carrying three distinct ones. The maximum levels of P. aeruginosa observed during the first week of life were variable among the infants: 1 x 10(3) to 1 x 10(10) CFU/g of stools. The levels diminished progressively afterwards, and after 1 year of age only 1 of the 13 infants examined remained a carrier of P. aeruginosa. In 11 infants a second or a third serotype occurred during the course of the study. The serotypes that appeared secondarily always disappeared before the initial ones. Antibiotics: ampicillin + gentamicin or cefotaxime + netilmicin and colistin which were given to 8 infants had no clear effect on P. aeruginosa levels. Four infants had delayed colonization by Escherichia coli of greater than or equal to 10 days. All 4 had high levels of P. aeruginosa: 1 x 10(7) to 1 x 10(10) CFU/g stool, and antibiotic therapy, rendering it impossible to assess which was the cause of this delay. This colonization by P. aeruginosa did not lead to any clinical trouble.


Asunto(s)
Recien Nacido Prematuro , Enfermedades Intestinales/microbiología , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/aislamiento & purificación , Cefotaxima/uso terapéutico , Colistina/uso terapéutico , Quimioterapia Combinada , Escherichia coli/aislamiento & purificación , Heces/microbiología , Femenino , Gentamicinas/uso terapéutico , Humanos , Recién Nacido , Recién Nacido Pequeño para la Edad Gestacional , Enfermedades Intestinales/tratamiento farmacológico , Masculino , Meconio/microbiología , Netilmicina/uso terapéutico , Infecciones por Pseudomonas/tratamiento farmacológico , Serotipificación , Ticarcilina/uso terapéutico , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA